Tag: Fortress Biotech

January 16, 2020

Cyprium Therapeutics Receives Designation for Menkes Treatment

Fortress Biotech's partner Cyprium Therapeutics’ has received Rare Pediatric Disease Designation from the FDA for its Menkes treatment.
July 4, 2019

5 Top NASDAQ Pharma Stocks Year-to-Date

We're halfway through the year, which means it's time to reflect on the top performing NASDAQ pharma stocks year-to-date.
April 3, 2019

5 Top NASDAQ Pharma Stocks Year-to-Date

The first quarter of the year is over, which means it's time to reflect on the top performing pharma stocks...
February 12, 2019

Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings

Fortress Biotech (NASDAQ: FBIO) has announced it completed the second and final stage of the previously-announced sale of its remaining holdings of...
February 10, 2019

5 Top Weekly NASDAQ Biotech Stocks: Index Slips

Melinta Therapeutics, BioXcel Therapeutics, Eyenovia, Forward Pharma and Trevena were last week's top gainers.
September 7, 2018

Checkpoint Therapeutics’ Share Price Dips on Preliminary Results

Checkpoint Therapeutics released preliminary results for its clinical trial on Thursday, but investors are not sharing the enthusiasm.